10 November 2017
EMA's unparalleled access to clinical data - one year on
One year ago, the European Medicines Agency (EMA) became the first regulatory authority to give open access to clinical data submitted by companies in support of their marketing authorisation applications. EMA’s initiative resulted in over 3,000 clinical documents published, 3,600 registered users and positive stakeholder feedback.
Read more about the initiative under www.ema.europa.eu.